Circ Cardi Interv:警惕冠脉导丝涂层脱落致远端栓塞

2015-02-09 高晓方 译 医学论坛网

荷兰一项研究表明,经皮冠脉介入治疗(PCI)后冠脉导丝亲水涂层脱落导致远端栓塞的情况较为常见。论文1月23日在线发表于《循环:心血管介入》(Circulation: Cardiovascular Interventions)。 此项研究对205例血栓抽吸物和40例尸检样本进行了评估,以明确冠脉导丝亲水涂层脱落并栓塞远端微血管系统的发生频率。 结果显示,45%的血栓切面存在异物,

荷兰一项研究表明,经皮冠脉介入治疗(PCI)后冠脉导丝亲水涂层脱落导致远端栓塞的情况较为常见。论文1月23日在线发表于《循环:心血管介入》(Circulation: Cardiovascular Interventions)。


此项研究对205例血栓抽吸物和40例尸检样本进行了评估,以明确冠脉导丝亲水涂层脱落并栓塞远端微血管系统的发生频率。

结果显示,45%的血栓切面存在异物,10%的尸检样本远端心肌可见亲水涂层栓塞。“HT Whisper”导丝应用后最可能发现异物(71%),其次为“HT BMW Universal”(46%)和“HT Floppy”(19%)

研究者表示,无论在稳定性心绞痛或因ST段抬高型心梗行经皮PCI的患者中,与冠脉导丝亲水涂层栓塞相关的临床后果仍均有待明确。尽管如此,目前推测心肌内动脉被异物阻塞所致微栓塞可影响心功能。未来需明确亲水涂层在通过和示踪方面的益处是否超过其远端栓塞风险。

除外导丝,医生还应注意导管和球囊含有的这种高分子涂层也有可能导致血管内栓塞。另外,亲水导丝也不尽相同,一些导丝的涂层可能更容易脱落。

原始出处:

Will Boggs,Distal Embolization of Coronary Guidewire Coating Common,Medscape February 04, 2015

Grundeken MJ1, Li X1, Kurpershoek CE1, Kramer MC1, Vink A1, Piek JJ1, Tijssen JG1, Koch KT1, Wykrzykowska JJ1, de Winter RJ1, van der Wal AC2.Distal embolization of hydrophilic-coating material from coronary guidewires after percutaneous coronary interventions.Circ Cardiovasc Interv. 2015 Feb;8(2). pii: e001816. doi: 10.1161/CIRCINTERVENTIONS.114.001816..


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1655238, encodeId=40861655238b4, content=<a href='/topic/show?id=05984668e6a' target=_blank style='color:#2F92EE;'>#导丝#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46687, encryptionId=05984668e6a, topicName=导丝)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98f124702487, createdName=lingqf, createdTime=Sun Mar 29 18:07:00 CST 2015, time=2015-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16358, encodeId=c3eb1635864, content=几率很小吧,没有遇到过, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200609/ef6a57dbe7f1489dad7446b7c5217858/d5e4fe65996c4446a029b0f5d056abb1.jpg, createdBy=6b011518214, createdName=午夜星河, createdTime=Wed Feb 18 10:24:00 CST 2015, time=2015-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16183, encodeId=ec10161831a, content=已阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da6b7222, createdName=chinayinhan, createdTime=Tue Feb 17 00:51:00 CST 2015, time=2015-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15845, encodeId=de5015845be, content=已阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c68e1614119, createdName=windmilL1989, createdTime=Mon Feb 16 14:22:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15540, encodeId=7cad1554076, content=是吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=928e1615200, createdName=jianlion, createdTime=Sun Feb 15 20:39:00 CST 2015, time=2015-02-15, status=1, ipAttribution=)]
    2015-03-29 lingqf
  2. [GetPortalCommentsPageByObjectIdResponse(id=1655238, encodeId=40861655238b4, content=<a href='/topic/show?id=05984668e6a' target=_blank style='color:#2F92EE;'>#导丝#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46687, encryptionId=05984668e6a, topicName=导丝)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98f124702487, createdName=lingqf, createdTime=Sun Mar 29 18:07:00 CST 2015, time=2015-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16358, encodeId=c3eb1635864, content=几率很小吧,没有遇到过, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200609/ef6a57dbe7f1489dad7446b7c5217858/d5e4fe65996c4446a029b0f5d056abb1.jpg, createdBy=6b011518214, createdName=午夜星河, createdTime=Wed Feb 18 10:24:00 CST 2015, time=2015-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16183, encodeId=ec10161831a, content=已阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da6b7222, createdName=chinayinhan, createdTime=Tue Feb 17 00:51:00 CST 2015, time=2015-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15845, encodeId=de5015845be, content=已阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c68e1614119, createdName=windmilL1989, createdTime=Mon Feb 16 14:22:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15540, encodeId=7cad1554076, content=是吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=928e1615200, createdName=jianlion, createdTime=Sun Feb 15 20:39:00 CST 2015, time=2015-02-15, status=1, ipAttribution=)]
    2015-02-18 午夜星河

    几率很小吧,没有遇到过

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1655238, encodeId=40861655238b4, content=<a href='/topic/show?id=05984668e6a' target=_blank style='color:#2F92EE;'>#导丝#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46687, encryptionId=05984668e6a, topicName=导丝)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98f124702487, createdName=lingqf, createdTime=Sun Mar 29 18:07:00 CST 2015, time=2015-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16358, encodeId=c3eb1635864, content=几率很小吧,没有遇到过, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200609/ef6a57dbe7f1489dad7446b7c5217858/d5e4fe65996c4446a029b0f5d056abb1.jpg, createdBy=6b011518214, createdName=午夜星河, createdTime=Wed Feb 18 10:24:00 CST 2015, time=2015-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16183, encodeId=ec10161831a, content=已阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da6b7222, createdName=chinayinhan, createdTime=Tue Feb 17 00:51:00 CST 2015, time=2015-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15845, encodeId=de5015845be, content=已阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c68e1614119, createdName=windmilL1989, createdTime=Mon Feb 16 14:22:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15540, encodeId=7cad1554076, content=是吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=928e1615200, createdName=jianlion, createdTime=Sun Feb 15 20:39:00 CST 2015, time=2015-02-15, status=1, ipAttribution=)]
    2015-02-17 chinayinhan

    已阅

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1655238, encodeId=40861655238b4, content=<a href='/topic/show?id=05984668e6a' target=_blank style='color:#2F92EE;'>#导丝#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46687, encryptionId=05984668e6a, topicName=导丝)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98f124702487, createdName=lingqf, createdTime=Sun Mar 29 18:07:00 CST 2015, time=2015-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16358, encodeId=c3eb1635864, content=几率很小吧,没有遇到过, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200609/ef6a57dbe7f1489dad7446b7c5217858/d5e4fe65996c4446a029b0f5d056abb1.jpg, createdBy=6b011518214, createdName=午夜星河, createdTime=Wed Feb 18 10:24:00 CST 2015, time=2015-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16183, encodeId=ec10161831a, content=已阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da6b7222, createdName=chinayinhan, createdTime=Tue Feb 17 00:51:00 CST 2015, time=2015-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15845, encodeId=de5015845be, content=已阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c68e1614119, createdName=windmilL1989, createdTime=Mon Feb 16 14:22:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15540, encodeId=7cad1554076, content=是吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=928e1615200, createdName=jianlion, createdTime=Sun Feb 15 20:39:00 CST 2015, time=2015-02-15, status=1, ipAttribution=)]
    2015-02-16 windmilL1989

    已阅

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1655238, encodeId=40861655238b4, content=<a href='/topic/show?id=05984668e6a' target=_blank style='color:#2F92EE;'>#导丝#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46687, encryptionId=05984668e6a, topicName=导丝)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98f124702487, createdName=lingqf, createdTime=Sun Mar 29 18:07:00 CST 2015, time=2015-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16358, encodeId=c3eb1635864, content=几率很小吧,没有遇到过, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200609/ef6a57dbe7f1489dad7446b7c5217858/d5e4fe65996c4446a029b0f5d056abb1.jpg, createdBy=6b011518214, createdName=午夜星河, createdTime=Wed Feb 18 10:24:00 CST 2015, time=2015-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16183, encodeId=ec10161831a, content=已阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da6b7222, createdName=chinayinhan, createdTime=Tue Feb 17 00:51:00 CST 2015, time=2015-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15845, encodeId=de5015845be, content=已阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c68e1614119, createdName=windmilL1989, createdTime=Mon Feb 16 14:22:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15540, encodeId=7cad1554076, content=是吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=928e1615200, createdName=jianlion, createdTime=Sun Feb 15 20:39:00 CST 2015, time=2015-02-15, status=1, ipAttribution=)]
    2015-02-15 jianlion

    是吗

    0

相关资讯

JACC:ST段抬高的心肌梗死患者接受急诊PCI治疗后的长短期死因

背景: 接受急诊经皮冠状动脉介入治疗(PCI)患者的短期死亡率已经被深入的研究,而ST段抬高的心肌梗死(STEMI)患者的长期死因仍是未知。目标:本研究的目的是描述STEMI患者接受急诊PCI的时间和死亡原因之间的关联。方法:一个集中居民登记习题,病人档案,有准确的记录链接的公共疾病和死亡原因的登记资料,被用来跟踪连续2804 名接受急诊PCI治疗的STEMI患者(年龄63±13岁,72%男性)的

Antioxid Redox Signal:阳光维生素造福心血管患者

近日,氧化应激生物医学领域最权威杂志《ANTIOXIDANTS & REDOX SIGNALING》(IF 7.7) 在线发表了仁济医院心内科何奔教授领衔团队的最新研究成果“Vitamin D receptor activation protects against myocardial reperfusion injury through inhibition of apoptosis

Circulation:患者心肌梗死后能过性生活吗?

对于患者在发生急性心肌梗死(AMI)后是否可恢复性生活的问题,美国和欧洲心脏学会相关指南均推荐,患者需咨询医生。但患者是否咨询了医生这个问题鲜为人知。近期的一项研究专门针对这个问题进行了研究,结果研究者们发现,向医生咨询上述问题的AMI患者非常少。研究者们进一步指出,当前证据或指南并不支持此类患者限制性生活的建议。研究论文2014年12月15日在线发表于《循环》(Cieculation)杂志。

J Dent Res:牙周病患病程度影响心肌梗死面积

有关牙周病与心肌梗死之间关联的研究已有很多。最近,西班牙研究人员进一步发现,慢性牙周病与心肌梗死之间还存在深层次的关联。 ( Image: decade3d - custom anatomy/Shutterstock ) 尽管有关牙周病与心肌梗死之间的关联在学界已讨论多年,然而,牙周病的患病程度是否会影响到心肌

Nature:外显子测序发现促心肌梗死风险基因

近日,来自美国的科学家在著名国际期刊Nature发表了他们的最新研究成果,他们通过对心肌梗死病人进行外显子测序发现两个蛋白编码基因的罕见突变可能会导致心肌梗死患病高风险。这项研究对临床预测心肌梗死发病,针对性开发治疗药物具有重要意义。   研究人员指出,心肌梗死(MI)是全世界范围内致死率非常高的一种疾病,具有复杂的遗传模式。对于早发性MI,基因遗传是一个主要的风险因素。之前已研究证

Diabetes 专家观点:“心-脾轴”可以影响心肌梗死的演变和心血管事件的发生

在上个世纪,心脏病专家和生理学家认为,急性心肌梗死是一个关于机体 “管道装置”出错导致氧气供需存在错配致使心肌细胞死亡的问题。有大量的研究一直在探测心肌细胞新陈代谢和对心肌缺血的干预措施,旨在通过恢复冠脉灌注或者减少氧耗来限制心肌的缺血性损伤。最近,关于心肌缺血性损伤也可以引起炎症反应的报道越来越多,炎症反应可以影响局部缺血的结局,进一步影响进行性梗死心肌的治疗。的确,几十年来临床医生已经注意到在